Loblaw's 8–10% Growth Target Is Real. So Is the Premium You Pay for It.

Loblaw did something it had not done in 14 years: it called an investor day and put numbers on its ambitions. On September 9, 2026, the Brampton-based food and drug retailer — Canada's largest, the operator of Loblaw, No Frills, Maxi and Shoppers Drug Mart — told institutional investors it is targeting 8% to 10% annual growth in adjusted diluted earnings per share over the long term, and that its newer businesses (supply chain as a service, retail media and data, the Lifemark healthcare unit, and T&T's U.S. expansion) should roughly double their slice of the earnings pie, from about 10% of operating income in 2026 to about 20% by 2031.

That target is the number to keep. The question is not whether Loblaw is a good company — it clearly is — it is whether an 8–10% earnings growth rate, delivered through hard-discount stores and pharmacies rather than AI, is worth the premium the market has already paid in.

A framework, not a press release

Most investor days are a marketing event with a growth theme bolted on. This one handed you a checklist. The 8–10% EPS target sits on top of a measured past: a 10.5% compounded adjusted-EPS growth rate from 2015 to 2025, so the long-term number is a commitment to sustain a pace the company has actually achieved. The growth-benchmark is specific — retail media has already crossed CAD 100 million of EBIT, and supply chain as a service is generating over CAD 200 million against a CAD 400 million target. That is the engine the multiple is supposed to justify, and it is real rather than rhetorical.

But Loblaw is no longer purely a grocery story, and the cleanest way to see why came a couple of months earlier. In July 2026 the company sold its PC Financial banking and insurance arm to Equitable Bank (EQB) for $625 million in cash — and kept roughly a 19.9% stake in the bank it just divested. From the third quarter of 2026 onward, Loblaw stops reporting PC Financial revenue as its own and instead books its proportionate share of EQB's income. The consequence is worth sitting with: the earnings behind that 8–10% target and that 10%-to-20% contribution are now a mix of retail and an equity stake in a bank. You are pricing a blended thing, and the "Retail and Beyond" label is doing real work here — the "beyond" is a stake in a challenger bank.

What the multiple is actually paying for

Strip the narrative and the factor question is simple: Loblaw trades at roughly 22 times forward earnings. Against the U.S. grocery set, that is a meaningful premium — Target sits at about 16 times trailing earnings, Costco at about 45. Loblaw is not cheap; it is paying up for the growth target relative to the median food retailer.

The earnings that justify the multiple are landing where the strategy points. In the second quarter of 2026, adjusted EPS grew 11.9% to $0.66, revenue rose 4.1% to CAD 15.3 billion, and the discount banners — Maxi and No Frills — outpaced the broader business. The company is in year two of a $10 billion, five-year Canadian investment program, with 2026 capex of about $2.4 billion and roughly $1.2 billion more still to deploy; management says new stores are running double-digit same-store sales growth as they mature. The consensus is a moderate buy, with a cluster of price targets around C$70.

The stock has already rallied about 106% over five years, so much of this credibility is in the price. The dividend is thin by design — roughly a 1% yield — because the company is recycling cash into buybacks (a planned ~$2.1 billion in 2026) and store capex rather than payouts.

What the factor stack says to do

For an investor who wants a large, defensive consumer staple with a credible earnings engine, Loblaw is a legitimate holding — a quality operator with a dividend it has raised for 15 straight years and a clear multi-year plan. But the honest read of the factor stack is Hold, not a fresh Buy: the 8–10% target is being paid for at about 22 times forward earnings, and a target is a target until the numbers deliver it.

What would change that is the growth-benchmark itself. If the contribution from retail media, supply chain, Lifemark and T&T's U.S. rollout actually moves toward 20% of operating income on schedule, the premium earns itself and the multiple re-rates. If those engines stall and the 8–10% rate comes entirely from grocery same-store sales and margin, the blended earnings — with a bank stake riding along — look expensive at 22 times forward. The 2031 doubling is the number to keep on the watch list; everything else is a story around it.